» Articles » PMID: 3599250

Examination of Strains of Lactobacilli for Properties That May Influence Bacterial Interference in the Urinary Tract

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1987 Aug 1
PMID 3599250
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Lactobacilli strains vary in their ability to interfere with colonization of uroepithelial cells by pathogenic organisms. Bacterial size, adherence capability, competitive exclusion and inhibition of pathogenic growth were examined in selected strains of lactobacilli to assess their relative importance. We tested adherence to uroepithelial cells of 34 lactobacillus isolates originating from the urogenital tract, dairy sources and chickens, and 1 lactobacillus strain isolated from a commercially available preparation. The ability to adhere differed greatly among the 34 strains, with a range of 8 to 74 bacteria per cell, and the commercial strain attached poorly with a mean of 15 bacteria per cell. Eleven strains of lactobacilli were selected and found to differ in length and width dimensions. These strains were found to exclude competitively with varying efficiency 6 strains of uropathogens from adhering to uroepithelial cells. The effective ability of Lactobacillus casei GR-1 to exclude the uropathogens confirmed previous findings and other strains (GR-2, GR-3 and A-60) gave a similar range of exclusion. The lactobacillus isolates varied greatly in their ability to inhibit the growth of 11 uropathogens under the conditions of an agar overlay inhibition assay. A combination score was allocated to each of the 11 lactobacillus strains based on size, adherence, exclusion and inhibition. Lactobacillus casei GR-1 attained the highest score while the commercial strain attained the lowest score. The results of this study identified 4 properties that should be examined to select lactobacillus strains before embarking upon bacterial interference studies to prevent urinary tract and other infections in humans.

Citing Articles

From whole genomes to probiotic candidates: A study of potential lactobacilli strains selection for vaginitis treatment.

Lyu J, Gao M, Zhao S, Liu X, Zhao X, Zou Y Heliyon. 2024; 10(9):e30495.

PMID: 38765070 PMC: 11098787. DOI: 10.1016/j.heliyon.2024.e30495.


Perspective: microbial interventions in the urinary tract.

Reid G Microbiome Res Rep. 2023; 2(1):3.

PMID: 38045610 PMC: 10688806. DOI: 10.20517/mrr.2022.17.


Role of the vaginal microbiome in miscarriage: exploring the relationship.

Saadaoui M, Singh P, Ortashi O, Al Khodor S Front Cell Infect Microbiol. 2023; 13:1232825.

PMID: 37780845 PMC: 10533927. DOI: 10.3389/fcimb.2023.1232825.


The interplay between human papillomavirus and vaginal microbiota in cervical cancer development.

Sharifian K, Shoja Z, Jalilvand S Virol J. 2023; 20(1):73.

PMID: 37076931 PMC: 10114331. DOI: 10.1186/s12985-023-02037-8.


Lactobacilli, a Weapon to Counteract Pathogens through the Inhibition of Their Virulence Factors.

Colautti A, Orecchia E, Comi G, Iacumin L J Bacteriol. 2022; 204(11):e0027222.

PMID: 36286515 PMC: 9664955. DOI: 10.1128/jb.00272-22.